Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Alana F. Ogata(University of Toronto), David R. Walt(Brigham and Women's Hospital), Salena S Von(Brigham and Women's Hospital), Amy C Sherman(Dana-Farber Cancer Institute), Megan Powell(Men's Health Boston), Chi‐An Cheng(Brigham and Women's Hospital), Lindsey R. Baden(Brigham and Women's Hospital), Lewis A. Novack(Brigham and Women's Hospital), Yasmeen Senussi(Brigham and Women's Hospital), Xiaofang Li(Brigham and Women's Hospital), Michaël Desjardins(Centre Hospitalier de l’Université de Montréal)
Cited by 236
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
|Clinical Infectious Diseases|2001|969